ASPET Journals
banner
aspetjournals.bsky.social
ASPET Journals
@aspetjournals.bsky.social
The five journals of the American Society for Pharmacology and Experimental Therapeutics, published by @elsevierconnect.bsky.social.

Learn more at: https://www.aspet.org/aspet/journals
📢 We're seeking a new Editor-in-Chief for the influential, impactful journal, Drug Metabolism and Disposition! 🧪

Nominees must be an ASPET member in good standing who served on an editorial board. An honorarium is provided, and nominations are due June 1.

Learn more: https://ow.ly/FGj350YcmsT
February 11, 2026 at 2:40 PM
🚨 LAST CHANCE! 🚨
Today is the final day to get the lowest rates for ASPET 2026! Prices increase tomorrow—don't miss your chance to save and attend the largest pharmacology event of the year.

🧪 Register now: https://www.aspet.org/ASPET2026/Registration
February 10, 2026 at 5:10 PM
Abiodun Wahab is this month's JPET Highlighted Trainee Author. Her research focuses on developing adjunct therapies that can be used alongside standard chemotherapy agents to reduce off-target toxicities while preserving their intended anticancer efficacy: https://doi.org/10.1016/j.jpet.2025.103794
February 9, 2026 at 3:15 PM
There are only a few days remaining to save on ASPET 2026! Register by Tuesday, February 10 to secure your spot and take advantage of early registration pricing: https://www.aspet.org/ASPET2026/Registration. 🧪
February 6, 2026 at 5:01 PM
Research from @ucdavis.bsky.social highlights cutting-edge advances in the pharmacology of voltage-gated Na⁺, Ca²⁺, and K⁺ ion channels (VGIC) and showcases how protein structures and AI are shaping next-generation VGIC therapeutics. 🧪#PharmRev pharmrev.aspetjournals.org/article/S003...
February 5, 2026 at 3:12 PM
ICYMI: Abstract submissions have reopened for ASPET 2026, and your research has the chance to be shared with a community of pharmacology researchers, students, and industry professionals!

📆 Deadline: February 19
🧪 Submit your abstract today: http://www.aspet.org/ASPET2026/Abstracts
January 30, 2026 at 6:01 PM
Sign up for the first in our new seminar series, Future Leaders in Pharmacology! Hosted in partnership with AMSPC, this series gives visibility to early career scientists who show promise as future leaders in the broad field of Pharmacology. 🧪
Sign up here: https://ow.ly/EgTF50Y5G5x
January 30, 2026 at 1:00 PM
#Cardiovascular diseases remain the leading cause of death worldwide, with lipid-lowering drugs playing a key role in risk management. This review dives into the evolution of lipid-lowering treatments: https://ow.ly/sXkl50Y5u7W
#PharmRev 🧪
January 29, 2026 at 4:12 PM
Curious about what goes on behind the scenes of ASPET journals? Dive into how our Editors-in-Chiefs and Publications Committee work to uphold scientific quality, support authors, and shape the future of research publishing: https://thepharmacologist.org/inside-aspets-journals/
January 28, 2026 at 5:45 PM
Sign up for today's free webinar! 🧪

Explore fundamentals of AI and its implications for pharmacy and healthcare education, using practical examples from courses in medical and PharmD programs. Register here: https://ow.ly/jgi650XXYAM

📢This webinar is open to both ASPET members & non-members.
January 28, 2026 at 1:58 PM
Check out this recent #PharmRev review to explore the use of metal-based agents conjugated to tumor-targeting molecules for the treatment of #breastcancer.

Read the research: https://pharmrev.aspetjournals.org/article/S0031-6997(25)07495-2/abstract
January 27, 2026 at 2:57 PM
Explore fundamentals of AI and its implications for pharmacy and healthcare education, using practical examples from courses in medical and PharmD programs, in this live webinar! Register here: https://ow.ly/8zqo50XXYAL

📢This webinar is free and open to both ASPET members & non-members. 🧪
January 20, 2026 at 2:01 PM
🧪 Read JPET's recent Editor's Choice, which suggests that inhibition of BRG1 could be a novel mechanism for combating paclitaxel resistance and enhancing the potency of chemotherapeutic agents: https://ow.ly/8jLk50XVJt3
January 15, 2026 at 4:18 PM
Rami Shahror, PhD, is the JPET Highlighted Trainee Author for January 2026. His research focuses on identifying proteins linked to harmful blood vessel formation in the retina due to ischemia, which can lead to retinopathy and vision loss.

➡️ Read here: https://doi.org/10.1016/j.jpet.2025.103738
January 15, 2026 at 3:45 PM
📢Make sure to sign up for today's webinar, designed for healthcare educators eager to enhance their teaching methodologies and student outcomes.

This webinar is open to both ASPET members AND non-members.🧪

Learn more and register here: https://ow.ly/HGy650XWSLV
January 15, 2026 at 1:00 PM
Congratulations to the 2026 recipients of an ASPET Editorial Fellowship. This program offers senior post-doctoral fellows and junior faculty members the opportunity to build important skills as a peer reviewer and as an editor.
January 12, 2026 at 2:02 PM
Vrishali Salian, PhD, a Postdoctoral Associate at the University of Minnesota, is the Molecular Pharmacology Highlighted Trainee Author for January 2026. Her research focuses on finding early warning signs of Alzheimer’s disease.

🔗 Read the research: https://doi.org/10.1016/j.molpha.2025.100088
January 6, 2026 at 3:30 PM
Congrats to the 4 recipients of Trainee Challenge Awards, awarded through a partnership w/ ASPET and the PhRMA Foundation, who have been recognized for their work in rapidly emerging areas in drug discovery research. Their award-winning research is free to read and share: https://ow.ly/V5jw50XR9Ws 🧪
January 5, 2026 at 3:01 PM
Modern antidiabetic drugs do more than lower sugar, they protect the heart and vessels. This review explains how. #PharmRev 🧪

https://ow.ly/nZLt50XMvsO
January 2, 2026 at 2:00 PM
Last chance!

PharmRev's Editor has selected the following article as free to read through December! We invite you to read this review that explores how marine-derived compounds are shaping the future of natural health products and modern pharmacology: https://ow.ly/8Jq150XBTGm 🧪
December 30, 2025 at 2:00 PM
Neuropeptides fine-tune the brain’s noradrenergic centre. This review maps how they regulate the locus coeruleus to shape behaviour. #PharmRev Danai Riga 🧪

https://ow.ly/SrCq50XMrCq
December 29, 2025 at 2:01 PM
Posttraumatic epilepsy remains untreatable. This review highlights new models and strategies for PTE prevention and therapy. #PharmRev #Epilepsy 🧪

https://ow.ly/EHRR50XMrre
December 26, 2025 at 2:01 PM
EPAC proteins reshape blood vessels. This review dissects cAMP-driven vascular remodeling and its therapeutic implications. #PharmRev #science 🧪
https://pharmrev.aspetjournals.org/article/S0031-6997(25)07486-1/abstract
December 24, 2025 at 2:01 PM
MolPharm's Editor-in-Chief has selected the following article as free-to-read through December 31, which unpacks the underlying mechanisms of nicotine addiction, offering valuable perspectives on receptor pharmacology and early dependence processes: https://ow.ly/9G3q50XBSRo 🧪
December 23, 2025 at 2:00 PM
Reprogramming cells to heal organs, this review explores breakthroughs in cell and tissue reprogramming for regenerative drug discovery. #PharmRev 🧪
https://ow.ly/9KGW50XMnLp
December 22, 2025 at 2:02 PM